NTLA
Price
$12.13
Change
+$1.01 (+9.08%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
1.26B
22 days until earnings call
OABI
Price
$2.20
Change
+$0.13 (+6.28%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
269.14M
Interact to see
Advertisement

NTLA vs OABI

Header iconNTLA vs OABI Comparison
Open Charts NTLA vs OABIBanner chart's image
Intellia Therapeutics
Price$12.13
Change+$1.01 (+9.08%)
Volume$110.88K
Capitalization1.26B
OmniAb
Price$2.20
Change+$0.13 (+6.28%)
Volume$29.57K
Capitalization269.14M
NTLA vs OABI Comparison Chart in %
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTLA vs. OABI commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a StrongBuy and OABI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (NTLA: $11.12 vs. OABI: $2.07)
Brand notoriety: NTLA and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 130% vs. OABI: 134%
Market capitalization -- NTLA: $1.26B vs. OABI: $269.14M
NTLA [@Biotechnology] is valued at $1.26B. OABI’s [@Biotechnology] market capitalization is $269.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 1 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • NTLA’s FA Score: 1 green, 4 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than OABI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 6 TA indicator(s) are bullish while OABI’s TA Score has 5 bullish TA indicator(s).

  • NTLA’s TA Score: 6 bullish, 4 bearish.
  • OABI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than OABI.

Price Growth

NTLA (@Biotechnology) experienced а +12.55% price change this week, while OABI (@Biotechnology) price change was +18.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.91%. For the same industry, the average monthly price growth was +17.27%, and the average quarterly price growth was +18.94%.

Reported Earning Dates

NTLA is expected to report earnings on Nov 06, 2025.

OABI is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+12.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.26B) has a higher market cap than OABI($269M). NTLA YTD gains are higher at: -4.631 vs. OABI (-37.853). OABI has higher annual earnings (EBITDA): -47.42M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. OABI (43.6M). OABI has less debt than NTLA: OABI (22.5M) vs NTLA (119M). NTLA has higher revenues than OABI: NTLA (45.6M) vs OABI (26.7M).
NTLAOABINTLA / OABI
Capitalization1.26B269M467%
EBITDA-530.8M-47.42M1,119%
Gain YTD-4.631-37.85312%
P/E RatioN/AN/A-
Revenue45.6M26.7M171%
Total Cash504M43.6M1,156%
Total Debt119M22.5M529%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLAOABI
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
52%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
41%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
66%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 20 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
53%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VEUAX38.630.32
+0.84%
JPMorgan Europe Dynamic A
FCPGX33.26N/A
N/A
Fidelity Small Cap Growth
EIVAX14.48N/A
N/A
Allspring Special Large Cap Value A
DTSGX16.62N/A
N/A
Wilshire Small Company Growth Invmt
SACVX34.79N/A
N/A
Spirit of America Large Cap Value C

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+8.49%
VCYT - NTLA
69%
Closely correlated
+0.91%
CRSP - NTLA
66%
Closely correlated
+7.09%
BEAM - NTLA
65%
Loosely correlated
+5.84%
RXRX - NTLA
57%
Loosely correlated
+8.72%
ABCL - NTLA
55%
Loosely correlated
-3.47%
More

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+6.28%
BEAM - OABI
40%
Loosely correlated
+5.71%
NTLA - OABI
39%
Loosely correlated
+9.08%
IMNM - OABI
38%
Loosely correlated
+3.98%
ALEC - OABI
37%
Loosely correlated
+8.55%
VIGL - OABI
37%
Loosely correlated
-0.12%
More